E. Ohman J:or Asset Management’s AbbVie ABBV Stock Holding History

E. Ohman J:or Asset Management’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$15.7M	Buy	62,362 +2,250	+4%	+$484K	0.36%	55
2026 Q1	$13.1M	Sell	60,112 -2,000	-3%	-$444K	0.35%	52
2025 Q4	$14.2M	Buy	+62,112	New	+$14.1M	0.33%	46
2023 Q1	–	Sell	-226,889	Closed	-$36.7M	–	424
2022 Q4	$36.7M	Sell	226,889 -28,010	-11%	-$4.29M	1.6%	12
2022 Q3	$34.2M	Sell	254,899 -9,678	-4%	-$1.39M	1.56%	11
2022 Q2	$40.5M	Sell	264,577 -9,590	-3%	-$1.47M	1.75%	10
2022 Q1	$44.4M	Buy	274,167 +242,060	+754%	+$35.2M	1.49%	13
2021 Q4	$4.35M	Sell	32,107 -46,900	-59%	-$5.54M	0.13%	103
2021 Q3	$8.52M	Buy	79,007 +2,500	+3%	+$286K	0.27%	68
2021 Q2	$8.62M	Buy	76,507 +5,700	+8%	+$642K	0.27%	71
2021 Q1	$7.66M	Buy	70,807 +34,800	+97%	+$3.72M	0.28%	67
2020 Q4	$3.86M	Sell	36,007 -2,700	-7%	-$259K	0.16%	92
2020 Q3	$3.39M	Sell	38,707 -2,300	-6%	-$217K	0.17%	81
2020 Q2	$4.03M	Buy	41,007 +6,507	+19%	+$573K	0.23%	71
2020 Q1	$2.63M	Sell	34,500 -2,800	-8%	-$238K	0.19%	69
2019 Q4	$3.3M	Sell	37,300 -28,800	-44%	-$2.39M	0.18%	79
2019 Q3	$5.01M	Buy	66,100 +3,100	+5%	+$213K	0.32%	57
2019 Q2	$4.58M	Buy	63,000 +3,000	+5%	+$236K	0.3%	56
2019 Q1	$4.84M	Sell	60,000 -4,200	-7%	-$344K	0.33%	58
2018 Q4	$5.92M	Sell	64,200 -8,600	-12%	-$756K	0.43%	52
2018 Q3	$6.89M	Buy	72,800 +7,200	+11%	+$683K	0.45%	54
2018 Q2	$6.08M	Buy	65,600 +20,300	+45%	+$1.98M	0.43%	55
2018 Q1	$4.29M	Sell	45,300 -2,200	-5%	-$242K	0.34%	60
2017 Q4	$4.59M	Buy	47,500 +4,900	+12%	+$462K	0.37%	58
2017 Q3	$3.79M	Buy	42,600 +2,000	+5%	+$152K	0.34%	63
2017 Q2	$2.94M	Sell	40,600 -2,300	-5%	-$155K	0.3%	68
2017 Q1	$2.8M	Buy	42,900 +4,500	+12%	+$283K	0.34%	64
2016 Q4	$2.4M	Buy	38,400 +3,500	+10%	+$214K	0.33%	61
2016 Q3	$2.2M	Buy	34,900 +1,800	+5%	+$117K	0.33%	63
2016 Q2	$2.05M	Buy	33,100 +3,100	+10%	+$189K	0.34%	67
2016 Q1	$1.71M	Sell	30,000 -3,000	-9%	-$167K	0.31%	70
2015 Q4	$1.95M	Hold	33,000	–	–	0.34%	69
2015 Q3	$1.8M	Sell	33,000 -3,000	-8%	-$195K	0.48%	49
2015 Q2	$2.42M	Buy	36,000 +2,700	+8%	+$176K	0.57%	41
2015 Q1	$1.95M	Hold	33,300	–	–	0.45%	52
2014 Q4	$2.21M	Sell	33,300 -2,400	-7%	-$151K	0.53%	41
2014 Q3	$2.06M	Hold	35,700	–	–	0.5%	42
2014 Q2	$2.01M	Sell	35,700 -2,700	-7%	-$142K	0.49%	41
2014 Q1	$1.97M	Hold	38,400	–	–	0.49%	41
2013 Q4	$2.04M	Sell	38,400 -2,100	-5%	-$103K	0.48%	44
2013 Q3	$1.81M	Buy	40,500 +3,000	+8%	+$133K	0.46%	46
2013 Q2	$1.55M	Buy	+37,500	New	+$1.64M	0.43%	47

Other funds holding ABBV

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return

Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return

Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return

Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return

New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return

ECSS

Eurizon Capital SGR SpA Milan $37.3B AUM

ATO

Alecta Tjanstepension Omsesidigt Stockholm, Sweden $23.8B AUM 34.25% 1-Year Est. Return

New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

E. Ohman J:or Asset Management's ABBV Position: Q2 2026 in Review

E. Ohman J:or Asset Management increased its AbbVie (ABBV) stake by 3.7% in Q2 2026, buying an estimated $484K and bringing the position to 62,362 shares worth $15.7M. The position accounts for 0.36% of the portfolio, ranked #55.

E. Ohman J:or Asset Management first reported a position in ABBV in Q2 2013 and has held it in 42 quarters since. The position peaked at $44.4M in Q1 2022. 2,121 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

E. Ohman J:or Asset Management held 62,362 shares of AbbVie worth $15.7M as of Q2 2026.
E. Ohman J:or Asset Management bought 2,250 AbbVie shares in Q2 2026, an estimated $484K.
AbbVie made up 0.36% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #55 holding.
E. Ohman J:or Asset Management first reported a position in AbbVie in Q2 2013 and has held it in 42 quarters since.
E. Ohman J:or Asset Management's AbbVie position peaked at $44.4M in Q1 2022.
2,121 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.